- Home
- CLGN vs HHS Comparison
CLGN vs HHS Comparison
Compare CLGN & HHS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLGN
- HHS
- Stock Information
- Founded
- CLGN 2004
- HHS 1923
- Country
- CLGN Israel
- HHS United States
- Employees
- CLGN N/A
- HHS N/A
- Industry
- CLGN Industrial Specialties
- HHS Advertising
- Sector
- CLGN Health Care
- HHS Consumer Discretionary
- Exchange
- CLGN Nasdaq
- HHS Nasdaq
- Market Cap
- CLGN 51.3M
- HHS 52.3M
- IPO Year
- CLGN N/A
- HHS N/A
- Fundamental
- Price
- CLGN $3.77
- HHS $5.38
- Analyst Decision
- CLGN Strong Buy
- HHS
- Analyst Count
- CLGN 2
- HHS 0
- Target Price
- CLGN $12.50
- HHS N/A
- AVG Volume (30 Days)
- CLGN 13.5K
- HHS 23.6K
- Earning Date
- CLGN 11-27-2024
- HHS 11-14-2024
- Dividend Yield
- CLGN N/A
- HHS N/A
- EPS Growth
- CLGN N/A
- HHS N/A
- EPS
- CLGN N/A
- HHS N/A
- Revenue
- CLGN $650,000.00
- HHS $187,604,000.00
- Revenue This Year
- CLGN N/A
- HHS N/A
- Revenue Next Year
- CLGN $692.59
- HHS $4.05
- P/E Ratio
- CLGN N/A
- HHS N/A
- Revenue Growth
- CLGN N/A
- HHS N/A
- 52 Week Low
- CLGN $3.31
- HHS $5.31
- 52 Week High
- CLGN $6.99
- HHS $8.87
- Technical
- Relative Strength Index (RSI)
- CLGN 34.26
- HHS 32.48
- Support Level
- CLGN $3.60
- HHS $5.73
- Resistance Level
- CLGN $4.17
- HHS $5.98
- Average True Range (ATR)
- CLGN 0.19
- HHS 0.28
- MACD
- CLGN -0.05
- HHS 0.02
- Stochastic Oscillator
- CLGN 2.26
- HHS 7.87
About CLGN CollPlant Biotechnologies Ltd
CollPlant Biotechnologies Ltd is a regenerative and aesthetic medicine company focused on 3D bioprinting of tissues and organs and medical aesthetics. Its products are based on its rhCollagen (recombinant human collagen) produced with CollPlant's proprietary plant based genetic engineering technology. These products address indications for the diverse fields of tissue repair, aesthetics, and organ manufacturing. The revenues include income from business collaborators and sales of the BioInk product for the development of 3D bioprinting of organs and tissues, sales of rhCollagen for the medical aesthetics market, and sales in Europe of the products for tendinopathy and wound healing. The company operates in United States, which derives key revenue, Canada, Europe and Other, and Israel.
About HHS Harte-Hanks Inc.
Harte-Hanks Inc is a customer experience company. The Company operates three business segments: Marketing Services; Customer Care; and Fulfillment & Logistics Services. The company has a geographic presence in the United States and Other countries. The majority of the revenue is earned from the United States.